SCHEMBL13058527

SCHEMBL13058527

Cc1sc(-c2ccc(OC(F)F)cc2)nc1C1C(=O)[C@@H]2[C@H](C1=O)[C@H]1CC[C@@H]2O1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 2/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ PTPN11 Q06124 1/20 0.33
▸ PDE1A P54750 1/20 0.32
▸ PDE1B Q01064 1/20 0.32
▸ PDE1C Q14123 1/20 0.32
▸ HCRTR1 O43613 1/20 0.32
▸ HCRTR2 O43614 1/20 0.32
▸ MAT2A P31153 1/20 0.32
▸ ADORA2A P29274 1/20 0.31
▸ ADORA1 P30542 1/20 0.31
▸ F2RL3 Q96RI0 1/20 0.31
▸ PPARA Q07869 2/20 0.31
▸ PPARG P37231 1/20 0.31
▸ GRB2 P62993 1/20 0.31
▸ AOC3 Q16853 2/20 0.31
▸ GRM2 Q14416 1/20 0.31
▸ PPARD Q03181 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13058478 0.87 ALDH1A1 (0.39) RAB9AALDH1A1MAPTADORA2AADORA1
SCHEMBL13058529 0.87 MAPT (0.35) RAB9AALDH1A1GAAMAPTPTPN11
SCHEMBL13058554 0.85 PPARG (0.33) PPARAPPARGPDE2ABACE1
SCHEMBL13058549 0.84 CRHR1 (0.34) BACE1
SCHEMBL13058476 0.84 SMN1; SMN2 (0.36) RAB9AALDH1A1GAAMAPTPPARA
SCHEMBL10237989 0.84 ALDH1A1 (0.38) RAB9AALDH1A1GAAMAPTPDE1A
SCHEMBL13058548 0.83 NPC1 (0.40) RAB9AALDH1A1GAAMAPTPPARA
SCHEMBL13058493 0.82 KDM4E (0.34) GAAMAPTNPC1NPSR1
SCHEMBL13058480 0.82 RAB9A (0.38) RAB9AALDH1A1GAAMAPTPPARA
SCHEMBL13058507 0.82 MAPT (0.31) GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2188294-B1 TRICYCLIC BRIDGED CYCLOPENTANEDIONE DERIVATIVES AS HERBICIDES SYNGENTA LTD (GB) 2015-03-18 — — EP disclosed
US-8530667-B2 Herbicides SYNGENTA LIMITED (GB) 2013-09-10 — — US disclosed
US-8530667-B2 Herbicides SYNGENTA LIMITED (GB) 2013-09-10 — — US disclosed
US-20100298140-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2010-11-25 — — US disclosed
US-20100298140-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2010-11-25 — — US disclosed
WO-2009030450-A2 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2009-03-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298140-A1 NOVEL HERBICIDES DDT, CYP1B1, CYP1A1 RAB9A 3091/4885ALDH1A1 10/4885GAA 509/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback